Nutex Health (NASDAQ:NUTX) President Buys $23,705.64 in Stock

Nutex Health Inc. (NASDAQ:NUTX) President Warren Hosseinion acquired 252 shares of the firm’s stock in a transaction dated Thursday, March 19th. The stock was bought at an average price of $94.07 per share, with a total value of $23,705.64. Following the acquisition, the president directly owned 7,765 shares in the company, valued at $730,453.55. This represents a 3.35% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website.

Nutex Health Stock Up 6.5%

Shares of NASDAQ:NUTX traded up $5.78 during midday trading on Monday, reaching $94.77. The company had a trading volume of 141,962 shares, compared to its average volume of 205,966. Nutex Health Inc. has a 1-year low of $45.88 and a 1-year high of $193.07. The stock has a market cap of $660.54 million, a PE ratio of 10.54 and a beta of 0.04. The company has a quick ratio of 3.39, a current ratio of 3.41 and a debt-to-equity ratio of 0.70. The business’s 50 day moving average price is $120.56 and its 200 day moving average price is $125.28.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings results on Thursday, March 5th. The company reported $1.61 EPS for the quarter, missing the consensus estimate of $5.56 by ($3.95). The company had revenue of $151.68 million for the quarter, compared to analyst estimates of $258.82 million. Nutex Health had a net margin of 7.34% and a return on equity of 17.67%.

Institutional Trading of Nutex Health

Institutional investors and hedge funds have recently bought and sold shares of the business. State of Alaska Department of Revenue acquired a new stake in shares of Nutex Health in the third quarter valued at approximately $30,000. Islay Capital Management LLC bought a new stake in Nutex Health in the 4th quarter valued at $34,000. BNP Paribas Financial Markets raised its stake in Nutex Health by 966.7% in the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after acquiring an additional 290 shares during the period. Ameritas Investment Partners Inc. acquired a new stake in Nutex Health during the 2nd quarter valued at $44,000. Finally, Royal Bank of Canada boosted its position in Nutex Health by 752.4% during the fourth quarter. Royal Bank of Canada now owns 358 shares of the company’s stock worth $59,000 after purchasing an additional 316 shares during the period. Institutional investors own 5.32% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. Weiss Ratings reissued a “hold (c)” rating on shares of Nutex Health in a research note on Monday, December 29th. Wall Street Zen lowered shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a research report on Saturday, March 7th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.